Longevity Stack Protocol
Overview
The Longevity Stack is a comprehensive, year-round peptide program targeting the primary mechanisms of aging through strategic rotation of four core anti-aging peptides. Rather than taking everything simultaneously (which risks receptor saturation and cost inefficiency), peptides are cycled through the year to maintain maximal efficacy at each phase. Expected outcomes over 12+ months include measurable improvements in biological age markers, improved telomere dynamics, immune restoration, improved metabolic health, skin quality, and subjective vitality and resilience.
Core Components
| Peptide | Mechanism | Role in Stack |
|---|---|---|
| Epitalon | Telomerase activation, melatonin restoration | Telomere and circadian protection |
| MOTS-C | Mitochondrial exercise mimetic, metabolic health | Energy metabolism and cellular resilience |
| Thymosin Alpha-1 | Thymic T-cell restoration, immune regulation | Immune senescence reversal |
| GHK-Cu | ECM remodeling, gene expression reset | Tissue quality and anti-inflammatory |
Annual Rotation Schedule
Q1 (January-March): Immune + Metabolic Foundation
| Peptide | Dose | Frequency | Duration |
|---|---|---|---|
| Thymosin Alpha-1 | 1.6 mg SubQ | 2x/week | 8-12 weeks |
| MOTS-C | 5 mg SubQ | 3x/week | 8-12 weeks |
| GHK-Cu | Topical daily + 1 mg SubQ 2x/week | Ongoing topical | Continuous topical |
Q2 (April-June): Telomere + Tissue Focus
| Peptide | Dose | Frequency | Duration |
|---|---|---|---|
| Epitalon | 5-10 mg SubQ | Nightly | 10-20 day cycle |
| GHK-Cu | Topical + SubQ as Q1 | As above | Continuous |
| MOTS-C | 5 mg SubQ | 2x/week (maintenance) | As tolerated |
Q3 (July-September): Mitochondrial + Metabolic Optimization
| Peptide | Dose | Frequency | Duration |
|---|---|---|---|
| MOTS-C | 5-10 mg SubQ | 3x/week | 8-12 weeks |
| SS-31 | 2-5 mg SubQ | 3x/week | 8 weeks |
| GHK-Cu | Topical daily | Continuous | Continuous |
Q4 (October-December): Immune Reset + Year-End Epitalon Course
| Peptide | Dose | Frequency | Duration |
|---|---|---|---|
| Thymosin Alpha-1 | 1.6 mg SubQ | 2x/week | 8-10 weeks |
| Epitalon | 5-10 mg SubQ | Nightly | 10-20 day cycle (second annual course) |
| GHK-Cu | Topical daily | Continuous | Continuous |
Administration Notes
- GHK-Cu topical: The one constant throughout all four quarters — apply morning and evening to face/neck/hands without cycling
- All injectable peptides: SubQ with insulin syringe; rotate sites; reconstitute in bacteriostatic water
- Epitalon: Always nighttime dosing; 2 courses per year (spring and fall) is the standard clinical protocol
- Thymosin Alpha-1: Mon/Thu dosing pattern works well for 2x/week schedule
Cycling Philosophy
The rotation approach prevents receptor desensitization, distributes cost over the year, and allows each peptide to work at full potency. The GHK-Cu topical is maintained continuously because there is no evidence of tolerance with topical application and the gene expression benefits are cumulative.
Expected Timeline
- Months 1-3: Immune competence improving; metabolic markers normalizing; energy and sleep improving
- Months 4-6: Telomere protection accumulating (Epitalon); skin quality measurably improving
- Months 7-9: Mitochondrial efficiency optimized; metabolic resilience peak
- Months 10-12: Immune senescence significantly reversed; biological age markers improved vs baseline
- Year 2+: Cumulative benefits compound; annual telomere testing expected to show attenuation of age-related shortening
Monitoring
- Annual biological age testing (TruDiagnostic, Elysium Index, or equivalent epigenetic clock)
- Quarterly: CRP, IL-6, CBC with differential, metabolic panel
- Annual: telomere length, IGF-1, testosterone, thyroid panel
- Track subjective vitality, sleep quality, skin, and exercise performance quarterly
Contraindications
- Active cancer (all growth-promoting peptides contraindicated — full protocol suspended; Thymosin Alpha-1 may continue under oncologist guidance)
- Pregnancy or breastfeeding
- Organ transplant on immunosuppression (Thymosin Alpha-1 may conflict)
Sources
#protocol #longevity #antiaging #Epitalon #MOTSC #ThymosinAlpha1 #GHKCu #rotation #biological-age